Adverse reactions are ranked under headings of frequency using the following convention: Very common ≥1/10; Common ≥1/100 to <1/10; Uncommon ≥1/1000 to <1/100; Rare ≥1/10000 to <1/1000; Very rare <1/10000; Not known (cannot be estimated from the available data).
Blood and lymphatic system disorders: Not known: haemorrhagic disorder.
Immune system disorders: Not known: anaphylactoid reaction, hypersensitivity.
Psychiatric disorders: Common: nervousness.
Uncommon: depression.
Not known: agitation, anxiety, confusion, hallucination.
Nervous system disorders: Common: hyperkinesia.
Uncommon: somnolence.
Not known: ataxia, balance disorder, epilepsy, headache, insomnia.
Ear and labyrinth disorders: Not known: vertigo.
Gastrointestinal disorders: Not known: abdominal pain, abdominal pain upper, diarrhoea, nausea, vomiting.
Skin and subcutaneous tissue disorders: Not known: angioedema, dermatitis, pruritus, urticaria.
General disorders and administration site conditions: Uncommon: asthenia.
Investigations: Common: weight increased.
View ADR Monitoring Form